Matteo Mori
Matteo Mori
Post-doctoral Researcher, University of Milan
Verified email at unimi.it
Title
Cited by
Cited by
Year
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
LR Chiarelli, M Mori, D Barlocco, G Beretta, A Gelain, E Pini, M Porcino, ...
European journal of medicinal chemistry 155, 754-763, 2018
282018
Signal transducer and activator of transcription protein 3 (STAT3): An update on its direct inhibitors as promising anticancer agents
A Gelain, M Mori, F Meneghetti, S Villa
Current Medicinal Chemistry 26 (27), 5165-5206, 2019
112019
New chromane-based derivatives as inhibitors of Mycobacterium tuberculosis salicylate synthase (MbtI): preliminary biological evaluation and molecular modeling studies
E Pini, G Poli, T Tuccinardi, LR Chiarelli, M Mori, A Gelain, L Costantino, ...
Molecules 23 (7), 1506, 2018
112018
An overview on the potential antimycobacterial agents targeting serine/threonine protein kinases from Mycobacterium tuberculosis
M Mori, JC Sammartino, L Costantino, A Gelain, F Meneghetti, S Villa, ...
Current Topics in Medicinal Chemistry 19 (9), 646-661, 2019
82019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
LR Chiarelli, M Mori, G Beretta, A Gelain, E Pini, JC Sammartino, ...
Journal of enzyme inhibition and medicinal chemistry 34 (1), 823-828, 2019
52019
Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism …
C Cerchia, R Nasso, M Mori, S Villa, A Gelain, A Capasso, F Aliotta, ...
Journal of medicinal chemistry 62 (15), 7089-7110, 2019
42019
Application of chiral bi-and tetra-dentate bispidine-derived ligands in the copper (II)-catalyzed asymmetric Henry reaction
A Rossetti, S Landoni, F Meneghetti, C Castellano, M Mori, GC Dugoni, ...
New Journal of Chemistry 42 (14), 12072-12081, 2018
42018
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation
E Truzzi, F Meneghetti, M Mori, L Costantino, V Iannuccelli, E Maretti, ...
Journal of colloid and interface science 541, 399-406, 2019
32019
Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design
M Mori, G Stelitano, A Gelain, E Pini, LR Chiarelli, JC Sammartino, G Poli, ...
Journal of Medicinal Chemistry 63 (13), 7066-7080, 2020
22020
Exploring the biological activity of a library of 1, 2, 5-oxadiazole derivatives endowed with antiproliferative activity
A Gelain, M Mori, F Meneghetti, F Porta, L Basile, G Marverti, A Asai, ...
Anticancer Research 39 (1), 135-144, 2019
22019
Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity
L Legnani, D Colombo, A Venuti, C Pastori, L Lopalco, L Toma, M Mori, ...
MedChemComm 8 (2), 422-433, 2017
22017
Crystallographic and NMR Investigation of Ergometrine and Methylergometrine, Two Alkaloids from Claviceps Purpurea
F Meneghetti, P Ferraboschi, P Grisenti, S Reza Elahi, M Mori, S Ciceri
Molecules 25 (2), 331, 2020
12020
Unravelling the Antiproliferative Activity of 1, 2, 5-oxadiazole Derivatives
D Ehrsam, F Porta, M Mori, HEM Zu Schwabedissen, L Dalla Via, ...
Anticancer research 39 (7), 3453-3461, 2019
2019
New synergic treatments for inhaled anti-TB therapy: a preliminary SANS study
M Mori, S Villa, A Gelain, G Beretta, LR Chiarelli, L Costantino, ...
Recent Development in Pharmaceutical Anlaysis, 2017
2017
Design and synthesis of novel antituberculars targeting the salicylate synthase (MbtI)
S Villa, LR Chiarelli, M Mori, A Gelain, L Costantino, D Bonanni, ...
Symposium on Medicinal Chjemistry for Global Health, 2017
2017
Synthesis of novel furan-based antitubercolars potentially targeting the methionine aminopeptidases (MtMetAP1a)
A Gelain, S Villa, M Mori, LR Chiarelli, L Costantino, T Tuccinardi, ...
World Congress on Medicinal Chemisty and Drug Design 7 (4), 74-74, 2017
2017
SANS study of lipid-based nanocarriers as inhaled drug delivery systems for anti-tuberculosis chemotherapy
F Meneghetti, C Castellano, M Mori, E Leo, V Iannuccelli, L Costantino, ...
Symposium on Medicinal Chemistry for Global Health, 1-1, 2017
2017
Design and synthesis of novel furan-based MbtI inhibitors as potential antitubercular agents
M Mori, S Villa, LR Chiarelli, A Gelain, C Luca, T Tiziano, L Margherita, ...
Merck Young Chemists Symposium, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–18